Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients," by Garbino et al. [2] (multiple letters)

Intensive Care Medicine

Volumn 29, Issue 7, 2003, Pages 1192-1196

  Van Saene, H K F ^a   Silvestri, L ^b   Petros, A ^c   Viviani, M ^d   De La Cal, M A ^e   Zandstra, D F ^f   Pittet, Didier ^g   Garbino, Jorge ^g   Hugonnet, Stéphane ^g   Romand, Jacques ^g   Lew, Daniel P ^g   Calandra, Thierry ^h   Marchetti, Oscar ^h  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Regional Hospital   (Italy)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^e HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^f ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFOTAXIME; COLISTIN; FLUCONAZOLE; PLACEBO; PYRROLE DERIVATIVE; TOBRAMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTEREMIA; CANDIDIASIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; FUNGUS TRANSMISSION; HIGH RISK PATIENT; HUMAN; HYGIENE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LETTER; META ANALYSIS; PATHOGENESIS; PNEUMONIA; RESPIRATORY TRACT INFECTION; SELECTIVE DIGESTIVE DECONTAMINATION; SYSTEMIC THERAPY; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ANTIFUNGAL AGENTS; CANDIDIASIS; CRITICAL ILLNESS; FLUCONAZOLE; HUMANS; NEUTROPENIA; PLACEBOS; RISK FACTORS;

EID: 0042667176     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1770-7     Document Type: Letter

References (0)